Peripheral Blood Stem Cell Mobilization in the Outpatient Setting

  • L. S. Schwartzberg

Abstract

The use of peripheral blood stem cells (PBSC) to support hematopoietic reconstitution after high-dose chemotherapy is now well established [1–4]. A variety of stimuli are capable of transiently mobilizing large numbers of progenitors into the peripheral blood rendering them accessible for harvest by repetitive leukapheresis. In contrast to stem cells collected via leukapheresis in the steady-state condition or from bone marrow harvest, mobilized PBSC have clearly shortened the recovery time of both granulocytes and platelets after high-dose myeloablative therapy [5–7].

Keywords

Toxicity Lymphoma Dexamethasone Half Life Neutropenia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Reiffers J, Bernard P, David B, et al. (1986) Successful autologous transplantation with peripheral blood hematopoietic cells in a patient with acute leukemia. Exp Hematol 14: 312–315PubMedGoogle Scholar
  2. 2.
    Fermand JP, Levy Y, Gerota J, et al. (1989) Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft. Blood 73: 20–23PubMedGoogle Scholar
  3. 3.
    Korbling M, Holle R, Haas R, et al. (1990) Autologous blood stem-cell transplantation in patients with advanced hodgkin’s disease and prior radiation to the pelvic site. J Clin Oncol 8: 978–985PubMedGoogle Scholar
  4. 4.
    Kessinger A, Armitage JO (1991) The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 77: 211–212PubMedGoogle Scholar
  5. 5.
    Juttner CA, To LB, Ho JQ, et al. (1988) Early lympho-hematopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. Transplant Proc 20: 40–42PubMedGoogle Scholar
  6. 6.
    Sheridan WP, Begley CG, Juttner CA, et al. (1992) Effect of peripheral blood progenitor cells mobilized by filgrastim ( G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339: 640PubMedCrossRefGoogle Scholar
  7. 7.
    To LB, Roberts MM, Haylock DN, et al. (1992) Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplantation 9: 277PubMedGoogle Scholar
  8. 8.
    To LB, Shepperd KM, Haylock DN. Single high-doses of cyclophosphamide enable the collection of high numbers of hematopoietic stem cells from the peripheral blood. Exp Hematol 18: 442–447Google Scholar
  9. 9.
    Sienna S, Bregni M, Brando B, et al. (1989) Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhanced by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74: 1904–1914Google Scholar
  10. 10.
    Gianni AM, Bregni M, Stern AC, et al. (1989) Granulocyte-macrophage colony- stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation. Lancet 11: 580–585CrossRefGoogle Scholar
  11. 11.
    Haas R, Ho AD, Bredthauer V, et al. (1990) Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 18: 94–98PubMedGoogle Scholar
  12. 12.
    Ravagnani F, Siena S, Bregni M, et al. (1990) Large-scale collection of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF. Eur J Cancer 26: 562–564PubMedCrossRefGoogle Scholar
  13. 13.
    Schwartzberg LS, Birch R, Hazelton B, et al. (1992) Peripheral blood stem cell mobilization by chemotherapy with and without rhG-CSF. J Hematotherapy 1: 317–328CrossRefGoogle Scholar
  14. 14.
    Lasky LC (1989) Hematopoietic reconstitution using progenitors recovered from blood. Transfusion 29: 552–557PubMedCrossRefGoogle Scholar
  15. 15.
    Camtin G, Marchand-Laroche D, Bouchard M-M, Blood-derived stem cell collection in acute non-lymphoblastic leukemia: Predictive values for a good yield. Exp Hematol 17: 991–996Google Scholar
  16. 16.
    Brugger W, Bross K, Frisch J, et al. (1992) Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony- stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. Blood 79: 1193–1200PubMedGoogle Scholar
  17. 17.
    Ciavarella D (1991) Hematopoietic stem cell processing and storage. In: Goldstein J (ed) Biotechnology of blood. Butterworth-Heinemann, Boston, pp 317–349Google Scholar
  18. 18.
    Kotasek D, Sage RE, Juttner CA, To LB (1992) Autologous transplantation in non- Hodgkin’s lymphomas using high-dose cyclophosphamide mobilized blood stem cells: The Adelaide experience. Int J of Cell Clon 10 [Suppl 1]: 129CrossRefGoogle Scholar
  19. 19.
    Juttner CA, To LB (1991) Peripheral stem cells: Mobilization by myelosuppressive chemotherapy. In: Dicke KA, Armitage JO, Dicke-Enger MJ (eds) Autologous Bone Marrow Transplantation Proc Fifth International Symposium, Omaha p 783–790Google Scholar
  20. 20.
    Craig JIO, Anthony RS, Smith SM, et al. (1992) Comparison of the Cobe Spectra and Baxter CS3000 Cell Separators for the collection of peripheral blood stem cells from patients with haematological malignancies. Int J of Cell Clon 10 [Suppl 1]: 82CrossRefGoogle Scholar
  21. 21.
    Bender J, To LB, Williams S, Schwartzberg L (1992) Defining a Therapeutic Dose of Peripheral Blood Stem Cells. J Hematotherapy 1: 329–342CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • L. S. Schwartzberg
    • 1
  1. 1.Response Technologies, Inc.MemphisUSA

Personalised recommendations